CANCER INC. (SPEC)

0

Screen Shot 2015-04-30 at 3.08.38 PM The true story of corporatization of cancer in the US told through the eyes of a British, Wall Street analyst who uncovers the corruption behind the approval of a drug intended to treat prostate cancer.

Share.